Intech Investment Management LLC Raises Holdings in STERIS plc $STE

Intech Investment Management LLC increased its stake in shares of STERIS plc (NYSE:STE) by 58.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 69,968 shares of the medical equipment provider’s stock after purchasing an additional 25,735 shares during the quarter. Intech Investment Management LLC’s holdings in STERIS were worth $17,738,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Board of the Pension Protection Fund purchased a new stake in shares of STERIS during the fourth quarter valued at approximately $25,000. Harbor Investment Advisory LLC raised its holdings in STERIS by 115.4% during the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 60 shares during the last quarter. Activest Wealth Management raised its holdings in STERIS by 423.8% during the 4th quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 89 shares during the last quarter. Cloud Capital Management LLC purchased a new stake in STERIS during the 3rd quarter valued at $29,000. Finally, Geneos Wealth Management Inc. boosted its position in STERIS by 416.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 104 shares during the period. 94.69% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at STERIS

In related news, Director Cynthia L. Feldmann sold 3,098 shares of STERIS stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $237.21, for a total transaction of $734,876.58. Following the sale, the director directly owned 705 shares in the company, valued at $167,233.05. The trade was a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.07% of the stock is currently owned by insiders.

Analyst Ratings Changes

STE has been the topic of a number of analyst reports. Weiss Ratings cut shares of STERIS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday. Piper Sandler restated an “overweight” rating and set a $270.00 price target on shares of STERIS in a report on Thursday, May 21st. KeyCorp lowered their price target on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a research report on Wednesday, May 13th. Finally, Wall Street Zen upgraded STERIS from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 16th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $278.00.

STERIS Stock Up 1.3%

Shares of NYSE STE opened at $215.54 on Friday. The firm has a fifty day simple moving average of $218.32 and a two-hundred day simple moving average of $241.13. STERIS plc has a 12 month low of $195.14 and a 12 month high of $269.44. The company has a current ratio of 2.09, a quick ratio of 1.54 and a debt-to-equity ratio of 0.25. The firm has a market capitalization of $21.14 billion, a PE ratio of 27.18 and a beta of 0.95.

STERIS (NYSE:STE) last announced its quarterly earnings results on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.86 by ($0.03). STERIS had a net margin of 13.18% and a return on equity of 14.15%. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the firm earned $2.74 EPS. STERIS’s quarterly revenue was up 6.7% compared to the same quarter last year. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Equities analysts expect that STERIS plc will post 11.18 earnings per share for the current year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be given a $0.63 dividend. The ex-dividend date of this dividend is Monday, June 8th. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. STERIS’s dividend payout ratio is currently 31.78%.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.